REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME side effect
What is REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME ?Drugs associated with REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME
ARANESP AVASTIN AVONEX BARACLUDE BEVACIZUMAB CARBOPLATIN CISPLATIN CYCLOPHOSPHAMIDE CYTARABINE DEXAMETHASONE DOXORUBICIN ENDOXAN FLUDARABINE GEMZAR HERCEPTIN INFLIXIMAB MABTHERA METHOTREXATE NASANYL NEXAVAR PRIMPERAN PROGRAF REBIF REMICADE SIROLIMUS SUTENT TACROLIMUS TARCEVA VIREADREVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Sutent Side Effects Report #5647662-9
Physician from UNITED KINGDOM reported SUTENT problem on Feb 20, 2008. Female patient, weighting 97.00 lb, was diagnosed with renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . SUTENT dosage: unknown. During the same period patient was treated with OXYCONTIN, MOVICOL. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Avastin Side Effects Report #5664276-5
AVASTIN problem was reported by a Physician from UNITED KINGDOM on Feb 29, 2008. Female patient, 62 years of age, was diagnosed with colon cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . AVASTIN dosage: 5 MG/KG, Q2W. During the same period patient was treated with OXALIPLATIN, FLUOROURACIL, ISOVORIN, AMOBAN, MAGNESIUM OXIDE, OXYCONTIN, RILMAZAFONE HYDROCHLORIDE, PAXIL. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Herceptin Side Effects Report #5677794-0
Consumer or non-health professional from UNITED STATES reported HERCEPTIN problem on Mar 19, 2008. Female patient, 56 years of age, was diagnosed with breast cancer metastatic and was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . HERCEPTIN dosage: 200 MG, UNK. During the same period patient was treated with ABRAXANE. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Baraclude Side Effects Report #5612497-X
BARACLUDE problem was reported by a Physician from JAPAN on Jan 30, 2008. Male patient, 36 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . BARACLUDE dosage: unknown. During the same period patient was treated with PREDONINE, MULTAMIN, MANGANESE CHLORIDE, GASTER, TAKEPRON, GABEXATE MESILATE. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Prograf Side Effects Report #5629951-7
Physician from JAPAN reported PROGRAF problem on Jan 28, 2008. Female patient was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . PROGRAF dosage: unknown. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Prograf Side Effects Report #5631740-4
PROGRAF problem was reported by a Physician from JAPAN on Jan 28, 2008. Female patient was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . PROGRAF dosage: unknown. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Viread Side Effects Report #5635091-3
Consumer or non-health professional from ITALY reported VIREAD problem on Feb 12, 2008. Male patient, 50 years of age, was treated with VIREAD. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . VIREAD dosage: unknown. During the same period patient was treated with EFAVIRENZ, LAMIVUDINE, PRAVASTATIN. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Doxorubicin Side Effects Report #5644337-7
DOXORUBICIN problem was reported by a Health Professional from FRANCE on Feb 25, 2008. Female patient, 33 years of age, was diagnosed with breast cancer and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . DOXORUBICIN dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Baraclude Side Effects Report #5644431-0
Physician from JAPAN reported BARACLUDE problem on Feb 26, 2008. Male patient, 36 years of age, was diagnosed with hepatitis b and was treated with BARACLUDE. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . BARACLUDE dosage: unknown. During the same period patient was treated with PREDONINE, MULTAMIN, MANGANESE CHLORIDE, FAMOTIDINE, TAKEPRON, GABEXATE MESYLATE. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Mabthera Side Effects Report #5594083-3
MABTHERA problem was reported by a Physician from UNITED KINGDOM on Jan 04, 2008. Female patient, 20 years of age, was diagnosed with evans syndrome and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . MABTHERA dosage: unknown. During the same period patient was treated with ENDOXAN, CALCIUM CARBONATE, SPECIAFOLDINE, TRIATEC, TARDYFERON. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Primperan Side Effects Report #5606629-7
Physician from JAPAN reported PRIMPERAN problem on Jan 24, 2008. Female patient was treated with PRIMPERAN. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . PRIMPERAN dosage: unknown. During the same period patient was treated with NASEA, DECADRON, GASTER D, MAGLAX, BEVACIZUMAB, FLUOROURACIL, ISOVORIN. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Avastin Side Effects Report #5610264-4
AVASTIN problem was reported by a Physician from UNITED STATES on Jan 23, 2008. Female patient was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . AVASTIN dosage: unknown. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Gemzar Side Effects Report #5511194-9
Physician from IRELAND reported GEMZAR problem on Oct 30, 2007. Female patient, 50 years of age, was diagnosed with non-small cell lung cancer metastatic, carotid artery stenosis and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . GEMZAR dosage: 1250 MG/M2, ON DAYS 1 AND 8. During the same period patient was treated with CISPLATIN, ATORVASTATIN CALCIUM, TINZAPARIN. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Methotrexate Side Effects Report #5482229-7
METHOTREXATE problem was reported by a Health Professional from UNITED STATES on Oct 01, 2007. Female patient, child 4 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DAUNORUBICIN, PREDNISONE, ASPARAGINASE. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Methotrexate Side Effects Report #5482235-2
Health Professional from UNITED STATES reported METHOTREXATE problem on Oct 01, 2007. Male patient, 13 years of age, was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DAUNORUBICIN, PREDNISONE, ASPARAGINASE. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Avastin Side Effects Report #5448241-9
AVASTIN problem was reported by a Pharmacist from UNITED STATES on Sept 06, 2007. Female patient, 49 years of age, weighting 132.3 lb, was diagnosed with non-small cell lung cancer and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . AVASTIN dosage: 900MG ONCE IV. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Nasanyl Side Effects Report #5468764-6
Physician from JAPAN reported NASANYL problem on Sept 14, 2007. Female patient was diagnosed with uterine leiomyoma and was treated with NASANYL. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . NASANYL dosage: unknown. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Tarceva Side Effects Report #5473209-6
TARCEVA problem was reported by a Physician from FRANCE on Sept 12, 2007. Male patient, 50 years of age, was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . TARCEVA dosage: unknown. During the same period patient was treated with SKENAN. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Cisplatin Side Effects Report #5408430-6
Health Professional from IRELAND reported CISPLATIN problem on Aug 06, 2007. Female patient, 50 years of age, was diagnosed with non-small cell lung cancer and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . CISPLATIN dosage: unknown. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Aranesp Side Effects Report #5422135-7
ARANESP problem was reported by a Health Professional from FRANCE on Aug 13, 2007. Female patient, 63 years of age, was diagnosed with anaemia of malignant disease and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . ARANESP dosage: unknown. During the same period patient was treated with DASATINIB, DEXAMETHASONE, NEOMYCIN. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Bevacizumab Side Effects Report #5422279-X
Pharmacist from UNITED STATES reported BEVACIZUMAB problem on Aug 20, 2007. Female patient, 78 years of age, weighting 140.0 lb, was diagnosed with colorectal cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . BEVACIZUMAB dosage: 10MG/KG Q2WKS IV. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Carboplatin Side Effects Report #5429310-6
CARBOPLATIN problem was reported by a Consumer or non-health professional from FRANCE on Aug 14, 2007. Female patient, 53 years of age, was diagnosed with lung adenocarcinoma stage iv and was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . CARBOPLATIN dosage: 260 MG, INFUSION. During the same period patient was treated with CISPLATIN, GEMCITABIN. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Cytarabine Side Effects Report #5383840-4
Physician from UNITED STATES reported CYTARABINE problem on June 26, 2007. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . CYTARABINE dosage: 500MG/M2 IV/EVERY 12 HRS FOR 6. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Aranesp Side Effects Report #5396425-0
ARANESP problem was reported by a Health Professional from FRANCE on July 16, 2007. Female patient, 63 years of age, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . ARANESP dosage: unknown. During the same period patient was treated with DEXAMETHASONE, NEOMYCIN. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Cytarabine Side Effects Report #5383840-4
Physician from UNITED STATES reported CYTARABINE problem on June 26, 2007. Male patient, 56 years of age, was diagnosed with acute myeloid leukaemia and was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . CYTARABINE dosage: 500MG/M2 IV/EVERY 12 HRS FOR 6. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Aranesp Side Effects Report #5396425-0
ARANESP problem was reported by a Health Professional from FRANCE on July 16, 2007. Female patient, 63 years of age, was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome, . ARANESP dosage: unknown. During the same period patient was treated with DEXAMETHASONE, NEOMYCIN. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Avastin Side Effects Report #5651824-4
Consumer or non-health professional from UNITED STATES reported AVASTIN problem on Feb 26, 2008. Female patient, 70 years of age, was diagnosed with breast cancer metastatic, pain and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: confusional state, reversible posterior leukoencephalopathy syndrome, . AVASTIN dosage: 595 MG, Q2W. During the same period patient was treated with PACLITAXEL, TOPROL, LEVOTHYROXINE, FENTANYL, MORPHINE, XANAX, ZOFRAN, CYMBALTA. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Remicade Side Effects Report #5662427-X
REMICADE problem was reported by a Physician from UNITED KINGDOM on Mar 05, 2008. Male patient, 14 years of age, weighting 70.55 lb, was diagnosed with crohn's disease, dyspepsia and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, reversible posterior leukoencephalopathy syndrome, visual disturbance, . REMICADE dosage: unknown. During the same period patient was treated with AZATHIOPRINE, MEBEVERINE, OMEPRAZOLE, PREDNISOLONE. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Remicade Side Effects Report #5662428-1
Physician from UNITED KINGDOM reported REMICADE problem on Mar 05, 2008. Male patient, weighting 72.09 lb, was diagnosed with crohn's disease, dyspepsia and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: crohn's disease, reversible posterior leukoencephalopathy syndrome, . REMICADE dosage: unknown. During the same period patient was treated with AZATHIOPRINE, OMEPRAZOLE, HYDROCORTISONE, POTASSIUM CHLORIDE, SULPHATE. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Sutent Side Effects Report #5633389-6
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 11, 2008. Female patient, weighting 164.9 lb, was diagnosed with renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: convulsion, reversible posterior leukoencephalopathy syndrome, syncope, . SUTENT dosage: unknown. During the same period patient was treated with LEXAPRO, NEXIUM, XANAX, MAGIC MOUTHWASH, MOTRIN. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Nexavar Side Effects Report #5635593-X
Health Professional from UNITED KINGDOM reported NEXAVAR problem on Feb 19, 2008. Female patient, 55 years of age, was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: confusional state, reversible posterior leukoencephalopathy syndrome, . NEXAVAR dosage: unknown. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Remicade Side Effects Report #5636680-2
REMICADE problem was reported by a Physician from UNITED KINGDOM on Feb 14, 2008. Male patient, 14 years of age, weighting 70.55 lb, was diagnosed with crohn's disease, dyspepsia and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: grand mal convulsion, reversible posterior leukoencephalopathy syndrome, visual disturbance, . REMICADE dosage: unknown. During the same period patient was treated with AZATHIOPRINE, MEBEVERINE, OMEPRAZOLE, PREDNISOLONE. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Methotrexate Side Effects Report #5638132-2
Physician from UNITED STATES reported METHOTREXATE problem on Feb 12, 2008. Female patient was diagnosed with lymphoproliferative disorder and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: pancreatitis, reversible posterior leukoencephalopathy syndrome, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, DAUNORUBICIN, PREDNISONE, PEG ASPARAGINASE, FLUDARABINE, CYTARABINE. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Endoxan Side Effects Report #5581384-8
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 26, 2007. Female patient, 20 years of age, was diagnosed with evans syndrome and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: convulsion, reversible posterior leukoencephalopathy syndrome, . ENDOXAN dosage: unknown. During the same period patient was treated with MABTHERA, TARDYFERON, TRIATEC, SPECIAFOLDINE, EUCALCIC. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Remicade Side Effects Report #5480149-5
Physician from UNITED STATES reported REMICADE problem on Sept 28, 2007. Female patient, weighting 162.0 lb, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: convulsion, reversible posterior leukoencephalopathy syndrome, . REMICADE dosage: unknown. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Dexamethasone Side Effects Report #5481784-0
DEXAMETHASONE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2007. Female patient, 48 years of age, was treated with DEXAMETHASONE. After drug was administered, patient experienced the following problems/side effects: hypertension, reversible posterior leukoencephalopathy syndrome, . DEXAMETHASONE dosage: 4 MG; Q6H; PO. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Methotrexate Side Effects Report #5487281-0
Physician from UNITED STATES reported METHOTREXATE problem on Oct 01, 2007. Male patient, 13 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, reversible posterior leukoencephalopathy syndrome, . METHOTREXATE dosage: unknown. During the same period patient was treated with VINCRISTINE, PREDNISONE, METOCLOPRAMIDE. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Remicade Side Effects Report #5442896-0
REMICADE problem was reported by a Physician from UNITED KINGDOM on Aug 31, 2007. Male patient, weighting 72.09 lb, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: crohn's disease, reversible posterior leukoencephalopathy syndrome, . REMICADE dosage: unknown. During the same period patient was treated with AZATHIOPRINE, OMEPRAZOLE, HYDROCORTISONE, POTASSIUM CHLORIDE, SULPHATE. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Sirolimus Side Effects Report #5446469-5
Health Professional from UNITED KINGDOM reported SIROLIMUS problem on Sept 04, 2007. Male patient, child 10 years of age, weighting 66.14 lb, was diagnosed with kidney transplant rejection, bone disorder, hypertension, infection prophylaxis, nephrogenic anaemia and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: malignant hypertension, reversible posterior leukoencephalopathy syndrome, . SIROLIMUS dosage: unknown. During the same period patient was treated with ALFACALCIDOL, BENDROFLUAZIDE, RANITIDINE, NEORECORMON, NIFEDIPINE, NYSTATIN, PREDNISOLONE. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Sirolimus Side Effects Report #5449997-1
SIROLIMUS problem was reported by a Health Professional from UNITED KINGDOM on Sept 07, 2007. Male patient, child 10 years of age, weighting 66.14 lb, was diagnosed with kidney transplant rejection, bone disorder, hypertension, infection prophylaxis, acidosis, nephrogenic anaemia and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: malignant hypertension, reversible posterior leukoencephalopathy syndrome, . SIROLIMUS dosage: unknown. During the same period patient was treated with ALFACALCIDOL, BENDROFLUAZIDE, BICARBONATE, NEORECORMON, NIFEDIPINE, NYSTATIN, PREDNISOLONE. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Sirolimus Side Effects Report #5465888-4
Health Professional from UNITED KINGDOM reported SIROLIMUS problem on Sept 18, 2007. Male patient, child 10 years of age, weighting 66.14 lb, was diagnosed with kidney transplant rejection, bone disorder, hypertension, infection prophylaxis, acidosis, nephrogenic anaemia and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: malignant hypertension, reversible posterior leukoencephalopathy syndrome, . SIROLIMUS dosage: unknown. During the same period patient was treated with ALFACALCIDOL, BENDROFLUAZIDE, BICARBONATE, NEORECORMON, NIFEDIPINE, NYSTATIN, PREDNISOLONE. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Prograf Side Effects Report #5409825-7
PROGRAF problem was reported by a Physician from JAPAN on July 25, 2007. Male patient, 14 years of age, was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: hypertension, reversible posterior leukoencephalopathy syndrome, . PROGRAF dosage: unknown. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Prograf Side Effects Report #5409826-9
Physician from JAPAN reported PROGRAF problem on July 25, 2007. Male patient, child 10 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: hypertension, reversible posterior leukoencephalopathy syndrome, . PROGRAF dosage: unknown. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Sirolimus Side Effects Report #5382797-X
SIROLIMUS problem was reported by a Health Professional from UNITED STATES on July 02, 2007. Female patient, 39 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: encephalopathy, reversible posterior leukoencephalopathy syndrome, . SIROLIMUS dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, ANTITHYMOCYTE IMMUNOGLOBULIN, FLUDARABINE PHOSPHATE, MELPHALAN. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Sirolimus Side Effects Report #5382797-X
Health Professional from UNITED STATES reported SIROLIMUS problem on July 02, 2007. Female patient, 39 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with SIROLIMUS. After drug was administered, patient experienced the following problems/side effects: encephalopathy, reversible posterior leukoencephalopathy syndrome, . SIROLIMUS dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, ANTITHYMOCYTE IMMUNOGLOBULIN, FLUDARABINE PHOSPHATE, MELPHALAN. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Methotrexate Side Effects Report #5650739-5
METHOTREXATE problem was reported by a Consumer or non-health professional from JAPAN on Feb 27, 2008. Male patient, 54 years of age, was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: cardiac failure, pneumonia, reversible posterior leukoencephalopathy syndrome, thrombotic microangiopathy, venoocclusive disease, . METHOTREXATE dosage: unknown. During the same period patient was treated with CYCLOSPORINE. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Fludarabine Side Effects Report #5635614-4
Consumer or non-health professional from UNITED STATES reported FLUDARABINE problem on Feb 07, 2008. Male patient, child 8 years of age, was diagnosed with immunosuppression, prophylaxis against graft versus host disease and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: cystitis haemorrhagic, pneumonia, reversible posterior leukoencephalopathy syndrome, . FLUDARABINE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHYLPREDNISOLONE. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Rebif Side Effects Report #5507776-0
REBIF problem was reported by a Physician from FRANCE on Oct 19, 2007. Female patient was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: convulsion, hypertension, reversible posterior leukoencephalopathy syndrome, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Cyclophosphamide Side Effects Report #5513862-1
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on Nov 09, 2007. Female patient, weighting 95.24 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: mental status changes, musculoskeletal pain, reversible posterior leukoencephalopathy syndrome, status epilepticus, . CYCLOPHOSPHAMIDE dosage: 576 MG. During the same period patient was treated with DOXIL, RITUXIMAB, VINCRISTINE SULPHATE, LACTULOSE, LEVTHROID, LOVENOX, COZAAR, DARVON. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Doxorubicin Side Effects Report #5481350-7
DOXORUBICIN problem was reported by a Health Professional from UNITED STATES on Oct 01, 2007. Male patient, child 9 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, constipation, reversible posterior leukoencephalopathy syndrome, . DOXORUBICIN dosage: unknown. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, CYTARABINE, PREDNISONE, DEXRAZOXANE. Patient was hospitalized. Patient recovered.
REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME : Methotrexate Side Effects Report #5481799-2
Consumer or non-health professional from reported METHOTREXATE problem on Oct 02, 2007. Female patient, child 4 years of age, was diagnosed with b precursor type acute leukaemia, convulsion, hypertension and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: convulsion, hypertension, reversible posterior leukoencephalopathy syndrome, . METHOTREXATE dosage: unknown. During the same period patient was treated with PREDNISONE, VINCRISTINE, DAUNORUBICIN, ELSPAR, FOSPHENYTOIN, LEVETIRACETAM, AMLODIPINE. Patient was hospitalized. Patient recovered.